Search Results - "Debinski, H S"

Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults by Mann, S D, Debinski, H S, Kamm, M A

“…Background—Chronic idiopathic intestinal pseudo-obstruction, a syndrome of ineffectual motility due to a primary disorder of enteric nerve or muscle, is rare…”
Get full text

Colorectal polyp counts and cancer risk in familial adenomatous polyposis by Debinski, HS, Love, S, Spigelman, AD, Phillips, RK

“…BACKGROUND & AIMS: In familial adenomatous polyposis, colorectal cancer prevention is by prophylactic colectomy, but dietary or chemopreventative strategies…”
Get full text

DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction by Debinski, H S, Kamm, M A, Talbot, I C, Khan, G, Kangro, H O, Jeffries, D J

“…BACKGROUND: Hereditary forms of chronic idiopathic intestinal pseudo-obstruction (CIIP) are well described but the aetiology of most cases of sporadic CIIP is…”
Get full text

Factors Influencing Uptake of Genetic Testing For Colorectal Cancer Risk in an Australian Jewish Population by Warner, B. J., Curnow, L. J., Polglase, A. L., Debinski, H. S.

“…There is a significant excess of colorectal cancer in the Australian Ashkenazi Jewish community. This excess can partially be attributed to inherited factors…”
Get full text

Effect of sulindac on small polyps in familial adenomatous polyposis by Debinski, H S, Trojan, J, Nugent, K P, Spigelman, A D, Phillips, R K

Get more information

Upper intestinal surveillance in familial adenomatous polyposis by Debinski, H.S, Spigelman, A.D, Hatfield, A, Williams, C.B, Phillips, R.K.S

“…Our understancling of the natural history of upper gastrointestinal (GI) involvement in familial adenomatous polyposis (FAP) is still evolving, although we…”
Get full text

p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis by Kashiwagi, H., Spigelman, A. D., Talbot, I. C., Debinski, H. S., McKie, A. B., Lemoine, N. R., Phillips, R. K. S.

“…Background The genetic alterations in patients with familial adenomatous polyposis (FAP) and duodenal adenomas are poorly characterized when compared with data…”
Get full text

Electrogastrography in chronic intestinal pseudoobstruction by DEBINSKI, H. S, AHMED, S, MILLA, P. J, KAMM, M. A

“…This study aimed to characterize the disturbance of gastric electrical control activity in chronic intestinal pseudoobstruction (CIP) and to determine whether…”
Get full text

UDP glucuronosyltransferase in the cirrhotic rat liver by Debinski, H S, Mackenzie, P I, Lee, C S, Mashford, M L, Danks, J A, Tephly, T R, Green, M, Desmond, P V

“…In patients with cirrhosis, the elimination of drugs metabolized by glucuronidation is relatively preserved, in comparison with the metabolism of drugs by…”
Get more information

Novel drug therapies in inflammatory bowel disease by Debinski, H S, Kamm, M A

“…This paper reviews the published data on novel drug treatments for inflammatory bowel disease. Steroids that are topically active or rapidly metabolized have a…”
Get more information

Surveillance of ampullary adenomas in familial adenomatous polyposis by Kashiwagi, H, Spigelman, A D, Debinski, H S, Talbot, I C, Phillips, R K

Get more information

Evaluation of specific herpes DNA viruses in idiopathic megarectum and idiopathic megacolon by GATTUSO, J. M, DEBINSKI, H. S, KANGRO, H. O, JEFFRIES, D, KAMM, M. A

“…The aetiology of idiopathic megarectum and idiopathic megacolon is unknown. A previous study in patients with chronic idiopathic intestinal pseudo-obstruction,…”
Get full text

UDP-Glucuronosyltransferase in gilbert’s syndrome by Debinski, H.S., Lee, C.S., Dhillon, A.P., Mackenzie, P., Rhode, J., Desmond, P.V.

“…The diagnosis of Gilbert’s syndrome, a condition characterised by mild jaundice related to chronic unconjugated hyperbilirubinemia, is often presumptive and…”
Get full text

Localization of uridine 5'-diphosphate-glucuronosyltransferase in human liver injury by Debinski, H S, Lee, C S, Danks, J A, Mackenzie, P I, Desmond, P V

“…Pharmacokinetic studies in patients with cirrhosis have shown a decreased clearance of drugs metabolized by cytochrome P450, whereas drugs metabolized by…”
Get more information